Fidelis Capital Partners LLC Reduces Stock Position in Colgate-Palmolive Company $CL

Fidelis Capital Partners LLC cut its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 61.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,666 shares of the company’s stock after selling 8,909 shares during the period. Fidelis Capital Partners LLC’s holdings in Colgate-Palmolive were worth $453,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Brighton Jones LLC lifted its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares during the period. Woodline Partners LP increased its position in shares of Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Precision Wealth Strategies LLC bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $285,000. Pure Financial Advisors LLC lifted its stake in shares of Colgate-Palmolive by 30.0% in the 2nd quarter. Pure Financial Advisors LLC now owns 10,327 shares of the company’s stock worth $939,000 after purchasing an additional 2,385 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Colgate-Palmolive by 16.8% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 200,858 shares of the company’s stock worth $18,258,000 after buying an additional 28,875 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Q4 results beat Street estimates — EPS of $0.95 vs. $0.91 expected and revenue above consensus; management cited strong pricing and brand leadership as drivers of performance. Colgate Q4 Earnings Top Estimates, Strong Pricing Drives Results
• Positive Sentiment: Management issued FY?2026 revenue guidance that’s above consensus (guidance range provided), signaling confidence in sustained demand for essentials across key regions — a primary catalyst for the stock rally. Colgate-Palmolive forecasts upbeat annual sales as essentials spending holds firm
• Positive Sentiment: Core categories showed resilience — oral care and pet nutrition strength plus a Latin America rebound helped sales growth; Market commentary highlights this operating improvement as a near-term positive for margins and top-line momentum. Colgate-Palmolive’s Core Strength Lifts Q4 Results
• Positive Sentiment: Strong cash generation and shareholder returns: record operating cash flow and ~$2.9B returned to shareholders in the year — supports buyback/dividend expectations and investor confidence. Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results
• Neutral Sentiment: Analysts and models are being updated after the print — some price?target revisions were posted ahead/after the call; watch analyst notes for guidance sensitivity and margin assumptions. Colgate-Palmolive Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
• Negative Sentiment: Company recorded a large goodwill/intangible impairment tied to its skin?health business that drove a GAAP loss for the quarter — this one?time charge reduced headline EPS and highlights ongoing challenges in that segment. Colgate-Palmolive Swings to a Loss on Charges
• Negative Sentiment: Softer trends in China and margin pressure in parts of the portfolio were noted on the call — a reminder the recovery is uneven and could limit upside if those regions don’t stabilize. Colgate-Palmolive’s Core Strength Lifts Q4 Results

Analysts Set New Price Targets

A number of brokerages have commented on CL. Evercore ISI reduced their target price on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Barclays set a $83.00 target price on Colgate-Palmolive in a report on Friday, January 16th. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a report on Friday, January 16th. Finally, Piper Sandler restated an “overweight” rating and issued a $96.00 price target on shares of Colgate-Palmolive in a research report on Friday. Eleven investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $90.13.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $90.28 on Friday. The company has a market capitalization of $72.77 billion, a price-to-earnings ratio of 25.29, a PEG ratio of 5.74 and a beta of 0.30. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The stock’s 50-day simple moving average is $80.77 and its 200-day simple moving average is $81.43. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter last year, the company earned $0.91 EPS. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. As a group, analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.